Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.16%1.48M | 1.09%4.73M | 8.96%1.5M | 3.31%772.75K | 1.01%1.03M | -6.94%1.43M | 80.70%4.68M | 1.37M | 748K | 1.02M |
| Operating revenue | 3.16%1.48M | 1.09%4.73M | 8.96%1.5M | 3.31%772.75K | 1.01%1.03M | -6.94%1.43M | 80.70%4.68M | --1.37M | --748K | --1.02M |
| Cost of revenue | 5.79%956.85K | 5.03%3.14M | 18.18%1.02M | 4.78%531.84K | 1.32%686.19K | -4.15%904.48K | 96.46%2.99M | 859.14K | 507.57K | 677.24K |
| Gross profit | -1.32%522.33K | -5.85%1.6M | -6.46%480.34K | 0.20%240.91K | 0.40%344.73K | -11.34%529.34K | 58.31%1.69M | 513.53K | 240.44K | 343.37K |
| Operating expense | 18.22%251.78K | 19.21%961.97K | 10.02%265.17K | 21.02%221.14K | 35.01%262.51K | 91.80%212.98K | 95.00%806.94K | 241.03K | 182.73K | 194.44K |
| Selling and administrative expenses | 18.22%251.78K | 19.21%961.97K | 10.02%265.17K | 21.02%221.14K | 28.99%262.51K | 18.54%212.98K | 95.00%806.94K | --241.03K | --182.73K | --203.51K |
| -Selling and marketing expense | 50.99%70.59K | 26.82%252.77K | 55.05%80.28K | 5.02%55.43K | 50.06%70.32K | -2.40%46.75K | 80.29%199.31K | --51.77K | --52.78K | --46.87K |
| -General and administrative expense | 9.00%181.2K | 16.72%709.2K | -2.30%184.9K | 27.52%165.72K | 22.69%192.19K | 26.15%166.23K | 100.36%607.63K | --189.26K | --129.95K | --156.64K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.07K |
| Operating profit | -14.48%270.55K | -28.64%633.29K | -21.04%215.17K | -65.74%19.77K | -44.79%82.22K | -34.91%316.37K | 35.18%887.47K | 272.5K | 57.71K | 148.93K |
| Net non-operating interest income (expenses) | 51.92%-815 | 38.97%134.08K | -6.31%29.81K | 22.84%30.38K | 1,836.66%36.24K | 25.10%-1.7K | 116.28%96.48K | 31.82K | 24.73K | -2.09K |
| Non-operating interest income | ---- | 31.98%139.18K | -10.78%30.81K | 18.49%31.56K | --37.61K | --39.2K | 110.53%105.45K | --34.53K | --26.64K | ---- |
| Non-operating interest expense | -51.92%815 | -43.16%5.1K | -63.17%1K | -37.95%1.18K | -34.50%1.37K | -25.10%1.7K | 63.74%8.97K | --2.72K | --1.91K | --2.09K |
| Other net income (expenses) | 10.18%46.84K | -75.39%20.62K | -314.15%-27.92K | -82.85%6.41K | 38.82K | 42.51K | 311.38%83.82K | 13.04K | 37.37K | |
| Gain on sale of security | ---- | -95.15%3.57K | -492.95%-33.01K | -94.91%1.72K | --37.9K | ---3.04K | 277.23%73.52K | --8.4K | --33.7K | ---- |
| Other non-operating income (expenses) | 10.18%46.84K | 65.69%17.06K | 9.79%5.09K | 28.06%4.69K | --918 | --42.51K | 461.65%10.3K | --4.64K | --3.66K | ---- |
| Income before tax | -11.37%316.58K | -26.20%787.99K | -31.61%217.05K | -52.80%56.55K | 7.11%157.28K | -26.17%357.18K | 61.42%1.07M | 317.35K | 119.8K | 146.84K |
| Income tax | 1.02%79.14K | -18.47%241.22K | 12.39%106.77K | -53.19%16.22K | 1.06%39.89K | -38.20%78.35K | 65.42%295.89K | 95K | 34.64K | 39.47K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -14.85%237.43K | -29.16%546.76K | -50.40%110.28K | -52.63%40.34K | 9.33%117.39K | -21.89%278.84K | 59.94%771.88K | 222.35K | 85.16K | 107.37K |
| Net income continuous operations | -14.85%237.43K | -29.16%546.76K | -50.40%110.28K | -52.63%40.34K | 9.33%117.39K | -21.89%278.84K | 59.94%771.88K | --222.35K | --85.16K | --107.37K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -14.85%237.43K | -29.16%546.76K | -50.40%110.28K | -52.63%40.34K | 9.33%117.39K | -21.89%278.84K | 59.94%771.88K | 222.35K | 85.16K | 107.37K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -14.85%237.43K | -29.16%546.76K | -50.40%110.28K | -52.63%40.34K | 9.33%117.39K | -21.89%278.84K | 59.94%771.88K | 222.35K | 85.16K | 107.37K |
| Diluted earnings per share | -13.33%0.026 | -28.57%0.06 | -48.55%0.0124 | -52.69%0.0044 | 6.67%0.0128 | -23.08%0.03 | 58.49%0.084 | 0.0241 | 0.0093 | 0.012 |
| Basic earnings per share | -13.33%0.026 | -28.57%0.06 | -48.55%0.0124 | -52.69%0.0044 | 6.67%0.0128 | -23.08%0.03 | 58.49%0.084 | 0.0241 | 0.0093 | 0.012 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.